Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Total Liabilities (2018 - 2025)

Historic Total Liabilities for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $192.4 million.

  • Verastem's Total Liabilities rose 10431.19% to $192.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $192.4 million, marking a year-over-year increase of 10431.19%. This contributed to the annual value of $130.4 million for FY2024, which is N/A changed from last year.
  • Verastem's Total Liabilities amounted to $192.4 million in Q3 2025, which was up 10431.19% from $160.2 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Total Liabilities registered a high of $192.4 million during Q3 2025, and its lowest value of $16.2 million during Q3 2021.
  • Moreover, its 5-year median value for Total Liabilities was $66.2 million (2023), whereas its average is $76.9 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first crashed by 8156.53% in 2021, then surged by 19726.3% in 2022.
  • Verastem's Total Liabilities (Quarter) stood at $21.1 million in 2021, then surged by 125.84% to $47.7 million in 2022, then surged by 50.68% to $71.8 million in 2023, then skyrocketed by 81.62% to $130.4 million in 2024, then skyrocketed by 47.49% to $192.4 million in 2025.
  • Its Total Liabilities stands at $192.4 million for Q3 2025, versus $160.2 million for Q2 2025 and $164.1 million for Q1 2025.